Patents Assigned to AEterna Zentaris GmbH
  • Growth hormone secretagogues
    Patent number: 7297681
    Abstract: The invention relates to compounds of formula I which are useful for elevating the plasma level of growth hormone in a mammal as well as for the treatment of growth hormone secretion deficiency, growth retardation in child and metabolic disorders associated with growth hormone secretion deficiency.
    Type: Grant
    Filed: May 4, 2004
    Date of Patent: November 20, 2007
    Assignee: Æterna Zentaris GmbH
    Inventors: Jean Martinez, Jean-Alain Fehrentz, Vincent Guerlavais
  • Treatment of dementia and neurodegenerative diseases with intermediate doses of LHRH antagonists
    Patent number: 7288517
    Abstract: The present invention relates to the treatment of dementia and neurodegenerative diseases like Alzheimer's disease with intermediate doses of LHRH antagonists which do not cause a castration. A preferred LHRH antagonist is cetrorelix.
    Type: Grant
    Filed: April 27, 2002
    Date of Patent: October 30, 2007
    Assignee: AEterna Zentaris GmbH
    Inventors: Jürgen Engel, Rainer Voegeli
  • Pyridopyrazines and the use thereof as kinase inhibitors
    Patent number: 7276507
    Abstract: The invention relates to novel pyrido[2,3-b]pyrazine derivatives of the general Formula I, their preparation and use as medicaments, in particular for the treatment of malignant and other disorders based on pathological cell proliferations
    Type: Grant
    Filed: May 21, 2004
    Date of Patent: October 2, 2007
    Assignee: AEterna Zentaris GmbH
    Inventors: Eckhard Claus, Eckhard Günther, Irene Seipelt, Ulf R. Rapp, Ludmilla Wixler